CN111840316A - Specific medicinal powder for treating beriberi and preparation method thereof - Google Patents

Specific medicinal powder for treating beriberi and preparation method thereof Download PDF

Info

Publication number
CN111840316A
CN111840316A CN202010830116.3A CN202010830116A CN111840316A CN 111840316 A CN111840316 A CN 111840316A CN 202010830116 A CN202010830116 A CN 202010830116A CN 111840316 A CN111840316 A CN 111840316A
Authority
CN
China
Prior art keywords
powder
parts
oryzanol
vitamin
salicylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010830116.3A
Other languages
Chinese (zh)
Inventor
李威
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010830116.3A priority Critical patent/CN111840316A/en
Publication of CN111840316A publication Critical patent/CN111840316A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12Magnesium silicate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a specific medicinal powder for treating beriberi and a preparation method thereof, wherein the specific medicinal powder comprises the following ingredients: 2-4 parts of salicylic acid, 2-4 parts of talcum powder, 1-2 parts of oryzanol and 1-2 parts of vitamin B1 tablets, and is prepared by the following steps: s1, respectively grinding salicylic acid, talcum powder, oryzanol and vitamin B1 tablets until no granular sensation exists; s2, sequentially adding the ground salicylic acid powder, talcum powder, oryzanol powder and vitamin B1 powder into a container, and fully stirring until the mixture is uniformly mixed; and S3, subpackaging, sealing and storing. The medicinal powder prepared by the invention has the advantages of reasonable composition, small dosage, environmental protection, simple operation, obvious curative effect and little side effect.

Description

Specific medicinal powder for treating beriberi and preparation method thereof
Technical Field
The invention relates to the technical field of treating beriberi, in particular to specific medicinal powder for treating beriberi and a preparation method thereof.
Background
Beriberi is a very common disease, and the main causes of the beriberi are dampness and hyperhidrosis of the foot environment, fungus and mass propagation of bacteria are facilitated, so that the beriberi is generated, and the beriberi can be skinned and blister in a light person, and fester can be generated seriously, so that the physical and mental health and normal life of a patient are influenced, the patient can feel upset, and great inconvenience is brought to life and work.
Disclosure of Invention
In order to solve the problems, the technical scheme provided by the invention is that the specific medicinal powder for treating beriberi and the preparation method thereof are as follows: comprises the following ingredients and components: 2-4 parts of salicylic acid, 2-4 parts of talcum powder, 1-2 parts of oryzanol, 1-2 parts of vitamin B1 tablets,
is prepared by the following steps:
s1, respectively grinding salicylic acid, talcum powder, oryzanol and vitamin B1 tablets until no granular sensation exists;
s2, sequentially adding the ground salicylic acid powder, talcum powder, oryzanol powder and vitamin B1 powder into a container, and fully stirring until the mixture is uniformly mixed;
and S3, subpackaging, sealing and storing.
Compared with the prior art, the invention has the advantages that: the medicinal powder prepared by the invention has the advantages of reasonable composition, small dosage, environmental protection, simple operation, obvious curative effect and little side effect.
Detailed Description
Embodiment 1, a specific medicinal powder for treating beriberi and a preparation method thereof, comprising the following ingredients: 2 parts of salicylic acid, 2 parts of talcum powder, 1 part of oryzanol, 1 part of vitamin B1 tablets,
is prepared by the following steps:
s1, respectively grinding salicylic acid, talcum powder, oryzanol and vitamin B1 tablets until no granular sensation exists;
s2, sequentially adding the ground salicylic acid powder, talcum powder, oryzanol powder and vitamin B1 powder into a container, and fully stirring until the mixture is uniformly mixed;
and S3, subpackaging, sealing and storing.
Embodiment 2, a specific medicinal powder for treating beriberi and a preparation method thereof, comprising the following ingredients: 3 parts of salicylic acid, 3 parts of talcum powder, 2 parts of oryzanol, 2 parts of vitamin B1 tablets,
is prepared by the following steps:
s1, respectively grinding salicylic acid, talcum powder, oryzanol and vitamin B1 tablets until no granular sensation exists;
s2, sequentially adding the ground salicylic acid powder, talcum powder, oryzanol powder and vitamin B1 powder into a container, and fully stirring until the mixture is uniformly mixed;
and S3, subpackaging, sealing and storing.
When in use, the specific medicinal powder for treating the dermatophytosis is uniformly smeared on the affected side once or twice a day. The application is continued for 5-7 days until the healing is completed.
The present invention and the embodiments thereof have been described above without limitation, and those skilled in the art will be able to devise examples similar to the above embodiments without departing from the spirit and scope of the invention.

Claims (1)

1. The specific medicinal powder for treating beriberi and the preparation method thereof are characterized by comprising the following ingredients: 2-4 parts of salicylic acid, 2-4 parts of talcum powder, 1-2 parts of oryzanol and 1-2 parts of vitamin B1 tablets, and is prepared by the following steps:
s1, respectively grinding salicylic acid, talcum powder, oryzanol and vitamin B1 tablets until no granular sensation exists;
s2, sequentially adding the ground salicylic acid powder, talcum powder, oryzanol powder and vitamin B1 powder into a container, and fully stirring until the mixture is uniformly mixed;
and S3, subpackaging, sealing and storing.
CN202010830116.3A 2020-08-18 2020-08-18 Specific medicinal powder for treating beriberi and preparation method thereof Pending CN111840316A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010830116.3A CN111840316A (en) 2020-08-18 2020-08-18 Specific medicinal powder for treating beriberi and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010830116.3A CN111840316A (en) 2020-08-18 2020-08-18 Specific medicinal powder for treating beriberi and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111840316A true CN111840316A (en) 2020-10-30

Family

ID=72969167

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010830116.3A Pending CN111840316A (en) 2020-08-18 2020-08-18 Specific medicinal powder for treating beriberi and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111840316A (en)

Similar Documents

Publication Publication Date Title
CN101766551B (en) Drug toothpaste for treating oral diseases and preparation method thereof
CN102205055B (en) Medicament for repairing skin and preparation method thereof
CN111249289A (en) Oral care product or medicament for anti-inflammation and/or anti-allergy
CN101601750B (en) Specific beriberi medicament
CN111840316A (en) Specific medicinal powder for treating beriberi and preparation method thereof
CN101066285B (en) Application of aweto preparation in preparing medicine for treating skin diseases
CN102068617A (en) Pure Chinese herbal medicine inflammation-diminishing and sterilizing suspension liniment and preparation method thereof
CN103356697A (en) Stem cell preparation and oral fluid prepared therefrom
CN101590087A (en) A kind of composition and method of making the same of delaying female aging
WO2004028457A3 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
CN110755533A (en) Traditional Chinese medicine solution for treating skin diseases and preparation method and application thereof
US11052040B1 (en) Topical application and method of administration and absorption
CN104771418A (en) Foot-bath effervescent tablet and preparation method thereof
CN1085531C (en) Preparation for protecting liver and relieving acute alcoholism and its preparing method
CN100508989C (en) Medicinal powder for treating beriberi
CN1159055C (en) Medicine for treating beriberi and its preparing process
CN100400049C (en) Medicinal powder for treating beriberi and preparation method thereof
CN87103653A (en) Multifunctional lotion for dermatosis
CN100356965C (en) Pure natural medicine for treating burn and scald
CN1712009A (en) Externally-applied medicinal liquid for treating acne, rosacea and folliculitis
KR100806618B1 (en) Functional health foods comprising ?-polyglutamic acid for protecting, alleviating or controling allergies
CN106581663A (en) Composition for treating hormone-dependent dermatitis
CN112603929A (en) Formula for relieving or treating acne and using method
CN117414364A (en) Anti-aging composition and related application thereof
CN111514132A (en) Composition with effect of preventing and treating furuncle and carbuncle

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination